ChiCTR2000039761 版本V1.0 版本创建时间2020/11/08 00:39:50 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000039761 

最近更新日期:

Date of Last Refreshed on:

2020-11-08 00:39:46 

注册时间:

Date of Registration:

2020-11-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

该研究尚未获得伦理委员会批准,请于批准后再开始纳入参试者,并与我们联系上传批件。 广东省人民医院单中心大样本感染性心内膜炎临床研究

Public title:

A mono-centric and large-sample clinical study of infective endocarditis in Guangdong Province People’s Hospital

注册题目简写:

English Acronym:

研究课题的正式科学名称:

广东省人民医院单中心大样本感染性心内膜炎临床研究

Scientific title:

A mono-centric and large-sample clinical study of infective endocarditis in Guangdong Province People’s Hospital

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王维腾 

研究负责人:

简旭华 

Applicant:

Weiteng Wang 

Study leader:

Xuhua Jian 

申请注册联系人电话:

Applicant telephone:

15622734386

研究负责人电话:

Study leader's telephone:

13711736019

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

WangWt1996@126.com

研究负责人电子邮件:

Study leader's E-mail:

jianxuhuagz@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市中山二路106号

研究负责人通讯地址:

广东省广州市中山二路106号

Applicant address:

No 106,Zhongshan 2nd Street,Guangzhou,Guangdong Province

Study leader's address:

No 106,Zhongshan 2nd Street,Guangzhou,Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省人民医院

Applicant's institution:

Guangdong Province People’s Hospital

研究负责人所在单位:

广东省人民医院

Affiliation of the Leader:

Guangdong Province People’s Hospital

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广东省人民医院

Primary sponsor:

Guangdong Province People’s Hospital

研究实施负责(组长)单位地址:

广东省广州市中山二路106号

Primary sponsor's address:

No 106,Zhongshan 2nd Street,Guangzhou,Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省人民医院

具体地址:

中山二路106号

Institution
hospital:

Guangdong General Hospital

Address:

106 Second Zhongshan Street

经费或物资来源:

研究者自筹

Source(s) of funding:

Funding form the researchers

Target disease:

Infective endocarditis

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

感染性心内膜炎患者外科手术与内科保守治疗的疗效对比  

Objectives of Study:

A comparision of prognosis between surgical and medical treatment for patients with infective endocarditis

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

2010年-2020年广东省人民医院所收治的感染性心内膜炎住院患者,所有病人均以改良的Duke标准为依据明确诊断

Inclusion criteria

Form 2010 to 2020 all of patients with infective endocarditis who were in-hospital admission and diagnosed by the reformative standard of Duke in Guangdong Province Peoples Hospital were included

排除标准:

不符合改良的Duke标准或治疗后确诊的病人

Exclusion criteria:

Patients who cannot meet the reformative standard of Duke and were diagnosed after treatment were excluded

研究实施时间:

Study execute time:

From 2020-12-01 00:00:00 To 2023-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-12-01 00:00:00 To 2021-12-01 00:00:00  

干预措施:

Interventions:

组别:

外科治疗组

样本量:

200

Group:

Group in surgery

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

组别:

内科治疗组

样本量:

200

Group:

Group in medicine

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China 

Province:

Guangdong 

City:

Guangzhou 

单位(医院):

广东省人民医院 

单位级别:

三级甲等 

Institution
hospital:

Guangdong General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

心脏瓣膜功能

指标类型:

主要指标

Outcome:

cardiological valve function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

No random number sequence

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台ResMan:www.medresman.org

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Public management platform of clinic trial-Resman:www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集自广东省人民医院电子病历系统和纸质版病历档案,采集后的数据由广东省人民医院感染性心内膜炎研究中心数据管理委员会统一管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Statistics are collected form theElectronic medical record system of Guangdong General Hospital and the paper of case record form.All of the statistics are managed by the Data Management Committee of Center of Infective Endocarditis of Guangdong General Hospital.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-11-08 00:39:46